Explore

Trendline Trendline
IMMEDIATE Therapeutics Expands Leadership to Advance IMT-358 for Ischemic Therapy

IMMEDIATE Therapeutics Expands Leadership to Advance IMT-358 for Ischemic Therapy

IMMEDIATE Therapeutics Expands Leadership to Advance IMT-358 for Ischemic Therapy
Trendline Trendline
Coya Therapeutics Receives FDA Fast Track Designation for ALS Treatment COYA 302

Coya Therapeutics Receives FDA Fast Track Designation for ALS Treatment COYA 302

Coya Therapeutics Receives FDA Fast Track Designation for ALS Treatment COYA 302
Trendline Trendline
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy with AI Enhancement

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy with AI Enhancement

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy with AI Enhancement
Trendline Trendline
Zai Lab Secures FDA Fast Track for Zocilurtatug Pelitecan in Treating Aggressive Cancers

Zai Lab Secures FDA Fast Track for Zocilurtatug Pelitecan in Treating Aggressive Cancers

Zai Lab Secures FDA Fast Track for Zocilurtatug Pelitecan in Treating Aggressive Cancers
Trendline Trendline
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for Clinical Advancement

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for Clinical Advancement

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for Clinical Advancement
Trendline Trendline
Trisk Bio and NanoMosaic Partner to Enhance AAV Analytics with Tessie Platform

Trisk Bio and NanoMosaic Partner to Enhance AAV Analytics with Tessie Platform

Trisk Bio and NanoMosaic Partner to Enhance AAV Analytics with Tessie Platform
Trendline Trendline
JCR Pharmaceuticals to Showcase Gene Therapy Innovations at ASGCT Meeting in Boston

JCR Pharmaceuticals to Showcase Gene Therapy Innovations at ASGCT Meeting in Boston

JCR Pharmaceuticals to Showcase Gene Therapy Innovations at ASGCT Meeting in Boston
Trendline Trendline
Cellular Intelligence Licenses Novo Nordisk's Parkinson's Cell Therapy for AI-Enhanced Development

Cellular Intelligence Licenses Novo Nordisk's Parkinson's Cell Therapy for AI-Enhanced Development

Cellular Intelligence Licenses Novo Nordisk's Parkinson's Cell Therapy for AI-Enhanced Development
Trendline Trendline
Thryv Therapeutics to Present at Major Healthcare Conferences on SGK1 Inhibitors

Thryv Therapeutics to Present at Major Healthcare Conferences on SGK1 Inhibitors

Thryv Therapeutics to Present at Major Healthcare Conferences on SGK1 Inhibitors
Trendline Trendline
LIB Therapeutics Launches LEROCHOL in U.S. with Affordable Pricing Strategy

LIB Therapeutics Launches LEROCHOL in U.S. with Affordable Pricing Strategy

LIB Therapeutics Launches LEROCHOL in U.S. with Affordable Pricing Strategy
Trendline Trendline
AIRNA Unveils Promising Preclinical Data on RNA-Editing Therapeutics

AIRNA Unveils Promising Preclinical Data on RNA-Editing Therapeutics

AIRNA Unveils Promising Preclinical Data on RNA-Editing Therapeutics
Trendline Trendline
Thryv Therapeutics to Present SGK1 Inhibitor Progress at Major Healthcare Conferences

Thryv Therapeutics to Present SGK1 Inhibitor Progress at Major Healthcare Conferences

Thryv Therapeutics to Present SGK1 Inhibitor Progress at Major Healthcare Conferences